| Literature DB >> 27163294 |
François Drabo1, Hamado Ouedraogo1, Roland Bougma1, Clarisse Bougouma1, Issouf Bamba2, Dramane Zongo3, Mohamed Bagayan3,4, Laura Barrett2, Fanny Yago-Wienne2, Stephanie Palmer5, Brian Chu6, Emily Toubali5, Yaobi Zhang7.
Abstract
BACKGROUND: Burkina Faso is endemic with soil-transmitted helminth infections. Over a decade of preventive chemotherapy has been implemented through annual lymphatic filariasis (LF) mass drug administration (MDA) for population aged five years and over, biennial treatment of school age children with albendazole together with schistosomiasis MDA and biannual treatment of pre-school age children through Child Health Days. Assessments were conducted to evaluate the current situation and to determine the treatment strategy for the future. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2016 PMID: 27163294 PMCID: PMC4862685 DOI: 10.1371/journal.pntd.0004707
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Deworming activities through different platforms in Burkina Faso.
| Population groups | Treatment drugs | Treatment frequency | Period | MDA platform | Notes |
|---|---|---|---|---|---|
| Pre-school age children (12–59 months) | Mebendazole | Twice a year | Since 2007 | Vitamin A supplementation | Door-to-door distribution during Child Health Days that include vitamin A supplementation |
| School age children (5–14 years) | Albendazole | Once every two years | 2004–2006 | Schistosomiasis MDA (school- and community-based) | Albendazole treatment with praziquantel stopped after integration with LF MDA. |
| Total LF eligible population (≥5 years old) | Albendazole + ivermectin | Once a year (twice a year in 4 districts in Sud Ouest region) | Since 2001 | LF MDA (community-based) | Geographical coverage was gradually scaled up to 100% in 2005, and then has been gradually scaled down since 2012. |
Results of STH infections in school age children from the 22 sentinel sites in Burkina Faso in 2013.
| Regions | No of children examined | Hookworm | Overall STH | |
|---|---|---|---|---|
| Prevalence (%) (95% CI) | Mean egg count (epg) | Prevalence (%) (95% CI) | ||
| Boucle du Mouhoun | 429 | 0.6 (0.2–2.3) | 0.3 (0–0.7) | 0.6 (0.2–2.3) |
| Cascades | 169 | 1.9 (0.6–5.4) | 0.6 (0–1.3) | 1.9 (0.6–5.4) |
| Centre Est | 343 | 1.9 (0.9–4.0) | 1.0 (0.2–1.8) | 2.8 (1.5–5.3) |
| Centre Nord | 362 | 0 | 0 | 0 |
| Centre Ouest | 355 | 3.4 (1.9–6.1) | 14.9 (3.3–26.6) | 3.8 (2.2–6.4) |
| Centre Sud | 190 | 0.3 (0.1–1.8) | 0.1 (0–0.2) | 0.6 (0.2–2.3) |
| Est | 375 | 1.3 (0.5–3.2) | 0.8 (0–1.7) | 1.6 (0.7–3.7) |
| Hauts Bassins | 454 | 2.1 (1.1–3.8) | 2.2 (0–4.5) | 2.1 (1.1–3.8) |
| Nord | 353 | 0.3 (0.1–1.8) | 0.1 (0–0.2) | 0.3 (0.1–1.8) |
| Sahel | 296 | 0 | 0 | 0 |
| Sud Ouest | 187 | 0 | 0 | 0 |
Fig 1Prevalence of STH infections among school age children in 22 schistosomiasis sentinel sites, Burkina Faso from sentinel site surveys in 2008 and 2013.
Results of STH assessment during LF TAS and school-based survey in Centre Nord in Burkina Faso in 2014.
| Survey group | No of children examined | No of children positive | Estimated prevalence (%) (95% CI) | Critical cut-off value for <10% prevalence for cluster sampling [ | STH prevalence according to the cut-off value |
|---|---|---|---|---|---|
| 6–7 years old | 351 | 2 | 0.6 (0.2–2.1) | 1–20 | 2% to <10% |
| 10–14 years old | 345 | 7 | 2.0 (1.0–4.1) | 1–20 | 2% to <10% |
| 10–14 years old (school-based) | 250 | 0 | 0 (0–1.5) | - | - |
Fig 2Distribution of positive STH cases in surveyed clusters in the Centre Nord EU from the LF TAS-STH assessment in 2014.
A) 6–7 years old, B) 10–14 years old.